Bone marker alterations in patients with type 1 Gaucher disease

Area of Science:

• Biochemistry
• Metabolic Bone Disease
• Genetics

Background:

• Gaucher disease type I significantly impacts bone health, yet its pathophysiology remains unclear.
• Bone biopsies are invasive, limiting large-scale studies on Gaucher disease bone involvement.
• Non-invasive bone metabolism markers offer a viable alternative for assessing skeletal health in Gaucher patients.

Purpose of the Study:

• To investigate bone metabolism in type I Gaucher disease patients using non-invasive markers.
• To compare bone formation and resorption markers between Gaucher patients and a healthy control group.
• To explore potential correlations between bone density and disease-specific factors.

Main Methods:

• Evaluated 10 adult type I Gaucher patients with bone disease and a matched control group.
• Measured bone mineral density (BMD) and serum/urine markers of bone formation and resorption.
• Analyzed carboxyterminal propeptide of type I procollagen (PICP) and carboxyterminal telopeptide of type I collagen (ICTP) levels.

Main Results:

• Gaucher patients exhibited significantly lower PICP (bone formation) and higher ICTP (bone resorption) compared to controls.
• Osteopenia was observed in 60% of patients (mean Z-score of -1.04).
• No significant correlations were found between BMD and factors like age, sex, or spleen/liver volume.

Conclusions:

• Bone metabolism in Gaucher disease type I is characterized by a predominance of bone resorption over formation.
• Non-invasive bone turnover markers (PICP, ICTP) are sensitive indicators of altered bone metabolism in Gaucher disease.
• These markers show promise for monitoring therapeutic responses in Gaucher disease-related skeletal complications.